1. Home
  2. MMYT vs BLLN Comparison

MMYT vs BLLN Comparison

Compare MMYT & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MakeMyTrip Limited

MMYT

MakeMyTrip Limited

HOLD

Current Price

$41.03

Market Cap

4.2B

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$102.39

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MMYT
BLLN
Founded
2000
2016
Country
India
United States
Employees
N/A
713
Industry
Transportation Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.9B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
MMYT
BLLN
Price
$41.03
$102.39
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$101.00
$126.71
AVG Volume (30 Days)
858.5K
735.1K
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.83
$46.29
Revenue Next Year
$17.24
$30.14
P/E Ratio
$107.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.67
$61.96
52 Week High
$104.99
$138.70

Technical Indicators

Market Signals
Indicator
MMYT
BLLN
Relative Strength Index (RSI) 40.15 59.32
Support Level $39.07 $79.07
Resistance Level $51.24 $107.00
Average True Range (ATR) 2.35 7.98
MACD -0.29 0.71
Stochastic Oscillator 9.00 75.62

Price Performance

Historical Comparison
MMYT
BLLN

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: